CERo Therapeutics Holdings - Bathi resik saben saham sajrone 12 wulan pungkasan CERO

CERo Therapeutics (CERO) - logo korporat

By adhering to ethical testing standards and environmental waste disposal, CERo Therapeutics minimizes risks. The GURU.Markets portal provides this chart, where the annual net income per share TTM dynamics illustrate the current trend, and the value captures this metric. The company's revenues are based on innovations in cell therapy, while an intensive R&D pipeline featuring T-Chime technology ensures a technological breakthrough.

cero.bio (CERO): Bathi saben saham sajrone rolas wulan pungkasan saka 04.07.2022 nganti 18.11.2026

Rincian metrik keuangan lan pasar CERo Therapeutics Holdings (CERO)

Pambiji fundamental perusahaan:CERO CERo Therapeutics Holdings, Inc.
Barang unggulan cero.bio

Year-over-year (YoY) EPS growth (TTM) measures the percentage change in net income per share over a rolling twelve-month period. Investors analyze current EPS YoY TTM momentum to identify hidden fundamental trends between quarterly reports. This metric reflects the efficiency of profit capitalization. For CERo Therapeutics (CERO), this indicator is secondary, as biotech success depends on clinical trials rather than economic cycles. Profit dynamics here only indirectly indicate the cost of attracting R&D financing.